checkAd

     149  0 Kommentare Oncotelic Therapeutics, Inc. Awarded Top Cancer Immunotherapy Solutions Provider 2023 - Seite 3

    Contact Information:
    For Oncotelic Therapeutics, Inc.:
    Investor Relations
    ir@oncotelic.com


    Lesen Sie auch


    globenewswire
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 3 von 3

    Verfasst von globenewswire
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    Oncotelic Therapeutics, Inc. Awarded Top Cancer Immunotherapy Solutions Provider 2023 - Seite 3 AGOURA HILLS, Calif., Aug. 25, 2023 (GLOBE NEWSWIRE) - Oncotelic Therapeutics, Inc (OTCQB:OTLC) ("Oncotelic", the "Company" or "We" or “Our”), announced today it was featured in Life Sciences Review, Cancer Immunology Edition and has been awarded …